Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
03/05/2009 | US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
03/05/2009 | US20090060854 Dermatological Compound |
03/05/2009 | US20090060853 Aminophenylbenzothiazole compounds |
03/05/2009 | US20090060852 Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
03/05/2009 | US20090060851 Use of idebenone for the preparation of a topically-applied depigmentation composition and corresponding composition |
03/05/2009 | US20090060850 Ericacea extracts for combating skin aging |
03/05/2009 | DE102008038697A1 Agent, useful for the treatment of neurodermatitis and/or psoriasis, comprises a component of toothbrush tree, preferably Salvadora persica |
03/05/2009 | DE102007041735A1 Use of a multi-functional active substance mixture comprising a peptide fraction and an amino acid fraction, for producing a formulation for regulating the outer skin conditions of mammals including humans |
03/05/2009 | DE102007041491A1 Kosmetische Pflegecreme Cosmetic cream |
03/05/2009 | DE102007041475A1 Wirkstoffkombination aus Glycyrrhetinsäure und Erythrulose und kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombination enthaltend Active ingredient combination of glycyrrhetinic acid and Erythrulose and cosmetic or dermatological preparations, this drug combination containing |
03/05/2009 | DE102007041473A1 Use of glycyrrhetinic acid and/or glycyrrhizin for manufacturing cosmetic or dermatological preparations to strengthen the natural skin tanning, treat skin and hair and reduce wrinkles |
03/05/2009 | DE102007041472A1 Wirkstoffkombinationen aus Glycyrrhetinsäure und Dihydroxyaceton und kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombination enthaltend Active compound combinations of glycyrrhetinic acid and dihydroxyacetone and cosmetic or dermatological preparations, this drug combination containing |
03/05/2009 | CA2709546A1 Surgical hydrogel |
03/05/2009 | CA2697954A1 Sprayable composition comprising extract of red vine leaves |
03/05/2009 | CA2697862A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds |
03/05/2009 | CA2697670A1 Method for production of carotenoid |
03/04/2009 | EP2030626A1 Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
03/04/2009 | EP2030616A1 Short-chain fatty acid derivatives for treating pruritus |
03/04/2009 | EP2030612A1 Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) |
03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
03/04/2009 | EP2029600A1 Substituted pteridines substituted with a four-membered heterocycle |
03/04/2009 | EP2029145A2 Pyrrolopyrimidine compounds and their uses |
03/04/2009 | EP2029138A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
03/04/2009 | EP2029133A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
03/04/2009 | EP2029123A2 Use of a compound with rankl activity |
03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
03/04/2009 | EP1453507B1 Solubilized topoisomerase poison agents |
03/04/2009 | EP1452527B1 Azabicyclo compound, matrix metalloprotease inhibitor, and skin preparation |
03/04/2009 | EP1427720B1 3-substituted-4-pyrimidone derivatives |
03/04/2009 | EP1408931B1 Isotonic lipid emulsions |
03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
03/04/2009 | EP1085804B1 Method and composition for the treatment of epidermal irritations and infections |
03/04/2009 | CN101379089A Anti-ILT7 antibody |
03/04/2009 | CN101378747A Whitening dermatological preparations |
03/04/2009 | CN101378724A Skin-whitening cosmetic |
03/04/2009 | CN101376005A Method for configuring cosmetic product for nourishing face |
03/04/2009 | CN101375981A Chinese medicine preparation for treating tetanus, mouth ulcer, mastitis and trauma ulcer |
03/04/2009 | CN101375966A Medicinal liquor for treating recurrent psoriasis in progressive stage |
03/04/2009 | CN101375965A Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage |
03/04/2009 | CN101375960A Chinese medicinal composition for treating eczema and cutitis of children |
03/04/2009 | CN101375953A Chinese medicine for treating psoriasis |
03/04/2009 | CN101375933A Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
03/04/2009 | CN101375924A Externally appiled Chinese medicinal composition for treating chronic psoriasis in resting stage |
03/04/2009 | CN101375861A Chinese medicine medical ointment for treating recurrent psoriasis in progressive stage |
03/04/2009 | CN101375837A Medicament composition for treating dermatopathy as well as preparation method and use thereof |
03/04/2009 | CN100465279C A preparation and an application of epiderm or hair follicle stem cells from sources of human early embryo |
03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
03/04/2009 | CN100464779C Hair-culturing alopecia-preventing liquid or hair-culturing nourishing liquid and a preparation method thereof |
03/04/2009 | CN100464758C An application of Bijian grass in preparing medicines for treating diseases of tinea of hands, and tinea pedis |
03/04/2009 | CN100464741C An aqueous-alcoholic depigmenting gel with phenolic derivatives and the vitamer A |
03/03/2009 | US7498435 One amine is substituted with a fused heterocyclic ring and the other with a fused heterocyclic ring or phenyl ring, e.g., N2,N4-Bis(3,4-ethylenedioxyphenyl)-5-cyano-2,4-pyrimidinediamine; inhibit IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators such as histamine |
03/03/2009 | US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
03/03/2009 | US7498406 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
03/03/2009 | US7498358 Human ADAM-10 inhibitors |
03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
03/03/2009 | US7498038 Chitin microparticles and their medical uses |
03/03/2009 | US7498034 Imaging, diagnosis and treatment of disease |
03/03/2009 | US7498032 Methods for treating immune disorders or cancer with anti-CD40 antibodies |
03/03/2009 | CA2420222C Orally administered peptides to ameliorate atherosclerosis |
03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
03/03/2009 | CA2258165C N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
02/27/2009 | CA2599082A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds |
02/26/2009 | WO2009026158A2 Inflammation-regulating compositions and methods |
02/26/2009 | WO2009025797A1 Compositions and methods for treating symptoms of aging |
02/26/2009 | WO2009025328A1 Ascorbic acid derivative or salt thereof, method for producing the same, and cosmetic preparation |
02/26/2009 | WO2009025239A1 Novel preparation for external use |
02/26/2009 | WO2009024707A2 Use of radamea montana extract for preparing a cosmetic composition |
02/26/2009 | WO2009024680A1 Use of oleocanthal for treatment of cutaneous inflammation |
02/26/2009 | WO2009024677A2 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
02/26/2009 | WO2009024361A1 Hair treatment compositions with alcohol(s) and melatonin/agomelatine |
02/26/2009 | WO2009024360A1 Hair treatment compositions with surfactant(s) and melatonin/agomelatin |
02/26/2009 | WO2009024359A1 Hair treatment agent with conditioner(s) and melatonin/agomelatin |
02/26/2009 | WO2009023918A1 Method of producing plant extract formulations |
02/26/2009 | WO2008152330A3 Use of 4-phenyl-imidazole-2-thiones as tyrosinase inhibitors for preparing pharmaceutical or cosmetic compositions for treating or preventing pigment disorders |
02/26/2009 | WO2008135361A3 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
02/26/2009 | WO2008130607A3 Wound healing compositions containing keratin biomaterials |
02/26/2009 | WO2008030579A3 Irak modulators for treating an inflammatory condition, cell proliferative disorder, immune disorder |
02/26/2009 | US20090054522 Hair Care Product |
02/26/2009 | US20090054521 Zwitterionic compounds and use thereof |
02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
02/26/2009 | US20090054486 Polymorphic form xvi of fexofenadine hydrochloride |
02/26/2009 | US20090054451 Use of Piperidine Derivatives as Agonists of Chemokine Receptor Activity |
02/26/2009 | US20090054424 Optically active pyridine derivative and a medicament containing the same |
02/26/2009 | US20090054409 [4-(4-imidazo[1,2-a]pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-morpholin-4-yl-methanone, used for treating rheumatoid arthritis in mammals |
02/26/2009 | US20090054389 Topical Composition Comprising an Antibacterial Substance |
02/26/2009 | US20090054378 Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
02/26/2009 | US20090054349 Peptides for Promoting Hair Growth and Improving Wrinkle and Cosmetic Compositions Comprising the same |
02/26/2009 | US20090054346 Elastin production-enhancing agents |
02/26/2009 | US20090054323 Ang-2 inhibitor peptides; use treating tumors, eye disorders, bone disorders, psoriasis; angiogenesis inhibitors; amino acid sequence WDPWT |
02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
02/26/2009 | US20090054300 Using protein profiles aspredictive tools in prognosis and treatment of immune related disorders |
02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |